Trump nominates Heidi Overton to lead the FDA

Key Points:

• President Donald Trump announced he will nominate Dr. Heidi Overton, a White House domestic policy official and physician, as the new Food and Drug Administration (FDA) commissioner, praising her leadership and scientific insight.
• Overton, Trump's third choice for the role, has been involved in controversial health policies, including advocating for reduced childhood vaccination requirements and supporting the Supreme Court's decision overturning Roe v. Wade.
• If confirmed, Overton would replace Dr. Marty Makary, who resigned after policy clashes, and would lead the FDA amid ongoing challenges such as a multistate cyclospora outbreak and the agency's review of abortion pill regulations.
• Overton has publicly criticized Democratic leaders on abortion issues and participated in Trump's recent executive order aiming to lower the number of universally recommended childhood vaccinations from 18 to 11, urging "blue states" to adopt these revised guidelines.
• The timing of Overton’s official appointment announcement is expected soon, with the Senate confirmation process to follow amid continued political and public scrutiny of FDA policies.